8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
Pooled results from many studies on one question.
2019 / Systematic review of controlled trials
A systematic review searched six databases for randomized and nonrandomized controlled trials investigating whether dietary supplements or pharmacological agents affect TMAO concentrations in adults. Thirteen eligible trials were identified, comprising 6 studies on dietary supplements (mostly randomized controlled trials) and 7 on pharmacological agents. Different interventional products were tested, and the studies lacked the consistency to reliably synthesize evidence for the modifiability of TMAO concentrations by dietary supplements or pharmacological agents.
Kalagi NA, Abbott KA, Alburikan KA, et al. Adv Nutr, 2019. PMID 31073588
2019 / Systematic review
A systematic review synthesized evidence from 47 articles investigating potential risk factors for increased intestinal permeability. Strongest risk factors included Western-style dietary intake, elevated proinflammatory markers, dyslipidemia, hyperglycemia, insulin resistance, obesity-related anthropometric measures, comorbidity, and advanced disease severity. The authors noted that many identified factors reflected metabolic conditions external to the gut and that risk increased with multiple combined conditions.
Leech B, McIntyre E, Steel A, et al. Int J Clin Pract, 2019. PMID 31243854
2018 / Systematic review
A systematic review of 16 studies examined the effect of nutrients, foods, and food components in adults with functional dyspepsia (FD) or FD symptoms. Wheat-containing foods were implicated in symptom induction in six studies, and implementing a gluten-free diet showed symptom reduction. Dietary fat was associated with FD in all three studies measuring it, and caffeine was associated with FD in four studies, while alcohol associations remained uncertain. Symptom-inducing foods were reported as high in natural food chemicals, fermentable carbohydrates, or wheat/gluten.
Duncanson KR, Talley NJ, Walker MM, et al. J Hum Nutr Diet, 2018. PMID 28913843
2018 / Systematic review and meta-analysis of randomized placebo-controlled trials
A systematic review and meta-analysis of randomized placebo-controlled trials was conducted to evaluate the efficacy and safety of probiotics for infections in older adults. Fifteen articles totaling 5,916 participants (mean age 75.21 years) were analyzed. Probiotics showed no significant difference compared to placebo for infection occurrence (RR 0.90, 95% CI 0.76 to 1.08), adverse events (RR 1.01, 95% CI 0.91 to 1.12), mortality (RR 1.09, 95% CI 0.70 to 1.72), or mean duration of infection episodes (MD -0.35, 95% CI -1.57 to 0.87). The authors concluded that current low-quality evidence does not support using probiotics to reduce infections in older adults.
Wachholz PA, Nunes VDS, Polachini do Valle A, et al. Age Ageing, 2018. PMID 29415116
2018 / Systematic review and meta-analysis
A systematic review and meta-analysis of 228 trials (1970-2017) assessed whether probiotic strains have strain- and disease-specific efficacy in preventive and treatment indications with at least two randomized controlled trials per indication. Significant efficacy evidence was found for 7 (70%) of probiotic strain(s) among four preventive indications and 11 (65%) probiotic strain(s) among five treatment indications. For preventing adult antibiotic-associated diarrhea, specific Lactobacillus preparations (such as Bio-K+, Actimel, and L. reuteri 55730) demonstrated efficacy while other Lactobacillus strains did not. Significant disease-specific variations in efficacy were also shown for L. rhamnosus GG and Saccharomyces boulardii CNCM I-745, among other strains.
McFarland LV, Evans CT, Goldstein EJC Front Med (Lausanne), 2018. PMID 29868585
2018 / Systematic review of randomized controlled trials
Researchers evaluated harms reporting across 384 RCTs assessing probiotics, prebiotics, or synbiotics published between 2015 and 2018. No harms-related data were reported in 106 trials (28%), safety results were not reported in 142 (37%), and serious adverse events (SAEs) per group were omitted in 309 trials (80%). Overall, 375 trials (98%) lacked definitions for AEs/SAEs, numbers of participant withdrawals due to harms, or group-level AE/SAE counts with denominators. The authors concluded that harms reporting is often lacking or inadequate, precluding broad conclusions on the safety of these interventions.
Bafeta A, Koh M, Riveros C, et al. Ann Intern Med, 2018. PMID 30014150
2017 / Systematic review
A systematic review examined nine studies, comprising five quantitative and four qualitative reports on older individuals experiencing constipation. Constipation was linked to substantial disruptions in daily living, negative bodily experiences, and adverse psychological effects, impacting physical, mental, and social well-being. Participants also utilized individual management strategies shaped by their personal beliefs.
Tvistholm N, Munch L, Danielsen AK J Clin Nurs, 2017. PMID 27271918
2016 / Systematic review
A systematic review searched PubMed, EMBASE, and the Cochrane Library through October 2014 to assess lifestyle interventions for GERD. In 2 RCTs, weight loss was followed by decreased time with esophageal acid exposure (from 5.6% to 3.7% and from 8.0% to 5.5%), and prospective observational studies reported reduced reflux symptoms. In a prospective cohort study, tobacco smoking cessation was linked to reduced reflux symptoms in normal-weight individuals (odds ratio, 5.67). In RCTs, late evening meals increased supine acid exposure time compared with early meals (5.2% point change), and head-of-the-bed elevation decreased supine acid exposure time compared with a flat position (from 21% to 15%).
Ness-Jensen E, Hveem K, El-Serag H, et al. Clin Gastroenterol Hepatol, 2016. PMID 25956834
2016 / Meta-analysis
A meta-analysis of 86 studies encompassing 8,515,431 individuals across 22 countries assessed nonalcoholic fatty liver disease epidemiology. Global prevalence was 25.24% (95% CI: 22.10-28.65), with frequent comorbidities including obesity (51.34%) and type 2 diabetes (22.51%). Annual liver-specific mortality was 0.77 per 1,000 person-years in nonalcoholic fatty liver disease and 15.44 per 1,000 in nonalcoholic steatohepatitis.
Younossi ZM, Koenig AB, Abdelatif D, et al. Hepatology, 2016. PMID 26707365
2016 / Systematic review and meta-regression of intervention trials
A review of intervention trials examined how three fiber sources affect regularity in healthy participants. Cereal and vegetable fibers had similar positive impacts on stool weight, exceeding the effect of fruit fibers, with less fermentable fibers producing greater increases. In individuals with baseline transit times of 48 hours or longer, each gram of fiber from any source was linked to a transit reduction of about 30 minutes.
de Vries J, Birkett A, Hulshof T, et al. Nutrients, 2016. PMID 26950143
2016 / Systematic review
A systematic review searched Ovid/Medline from January 1996 to May 2015 to examine physical activity and exercise programs in chronic inflammatory bowel disease (CIBD). 12 of 16 published studies showed low habitual physical activity in CIBD, with sub-normal aerobic power, lean tissue mass, and muscular strength. Additionally, 3 of 4 studies suggested physical activity may reduce IBD risk, and 11 interventions reported that exercise programs were well tolerated with some decreases in disease activity, functional gains, and increased health-related quality of life. The authors note that more information on mechanisms is needed.
Shephard RJ Int J Sports Med, 2016. PMID 27116344
2016 / Systematic review and meta-analysis of observational studies
A systematic review and meta-analysis of 17 epidemiologic studies (13 case-control and 4 prospective cohort studies) examined the association between soy isoflavone intake and colorectal cancer (CRC) risk. Soy isoflavone consumption was associated with reduced CRC risk (RR: 0.78, 95% CI: 0.72-0.85; I2 = 34.1%, P = 0.024). Subgroup analyses showed significant reductions for soy foods/products (RR: 0.79, 95% CI: 0.69-0.89), in Asian populations (RR: 0.79, 95% CI: 0.72-0.87), and in case-control studies (RR: 0.76, 95% CI: 0.68-0.84). The authors noted that other factors may affect this association due to the limited number of studies.
Shows an association, not proof of cause and effect.
Yu Y, Jing X, Li H, et al. Sci Rep, 2016. PMID 27170217
2016 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis of seven randomized controlled trials evaluated the effects of fiber supplementation in adults with chronic idiopathic constipation. Overall, 77% (113 of 147) of patients assigned to fiber responded to therapy compared to 44% (61 of 140) allocated to placebo (RR 1.71, 95% CI 1.20-2.42, P = 0.003). Fiber significantly increased stool frequency (SMD 0.39, 95% CI 0.03-0.76, P = 0.03) and softened stool consistency (SMD 0.35, 95% CI 0.04-0.65, P = 0.02), but also significantly increased flatulence (SMD 0.56, 95% CI 0.12-1.00, P = 0.01). The overall quality of evidence was low, and findings need caution due to a high risk of bias.
Christodoulides S, Dimidi E, Fragkos KC, et al. Aliment Pharmacol Ther, 2016. PMID 27170558
2015 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis examined fiber supplementation across 22 randomized trials in outpatients with irritable bowel syndrome. Overall, participants allocated to fiber experienced greater improvement in global symptoms than those given placebo (risk ratio: 1.27, 95% CI 1.05-1.54). Soluble fiber specifically improved global symptoms (risk ratio: 1.49, 95% CI 1.09-2.03) and abdominal pain scores (mean difference: -1.84, 95% CI -2.72 to -0.97), whereas insoluble fiber did not improve any measured outcome.
Nagarajan N, Morden A, Bischof D, et al. Eur J Gastroenterol Hepatol, 2015. PMID 26148247
2015 / Meta-analysis of prospective cohorts
A meta-analysis of 17 prospective studies with 55,670 cases among 1,921,103 participants evaluated adiposity measures and gallbladder disease risk. Each 5-unit increase in BMI was associated with increased risk (RR = 1.63, 95% CI: 1.49-1.78), with risk almost doubling even within normal BMI ranges. Higher waist circumference (RR = 1.46 per 10 cm, 95% CI: 1.24-1.72) and waist-to-hip ratio were also associated with elevated gallbladder disease risk.
Shows an association, not proof of cause and effect.
Aune D, Norat T, Vatten LJ Eur J Epidemiol, 2015. PMID 26374741
2015 / Meta-analysis
A meta-analysis examined nine studies evaluating meat intake and inflammatory bowel disease risk. Compared with participants who ate no or rarely any meat, consuming meat was linked to an elevated risk of the condition (pooled RR 1.50, 95% CI 1.15-1.95). Funnel plot analysis detected no evidence of publication bias.
Ge J, Han TJ, Liu J, et al. Turk J Gastroenterol, 2015. PMID 26575042
2014 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis assessed the efficacy and safety of enteric-coated peppermint oil capsules versus placebo for active irritable bowel syndrome across 9 randomized trials with 726 patients. Peppermint oil was significantly superior to placebo for global symptom improvement (5 studies, 392 patients, RR 2.23; 95% CI, 1.78-2.81) and abdominal pain improvement (5 studies, 357 patients, RR 2.14; 95% CI, 1.64-2.79). Patients receiving peppermint oil were significantly more likely to experience adverse events, though these were mild and transient, with heartburn being the most common.
Khanna R, MacDonald JK, Levesque BG J Clin Gastroenterol, 2014. PMID 24100754
2014 / Systematic review and meta-analysis of randomized controlled trials
A systematic review of 26 randomized controlled trials with 831 participants evaluated dietary prebiotic supplementation. Prebiotics increased self-reported satiety in healthy adults (SMD -0.57, 95% CI -1.13 to -0.01) and decreased postprandial glucose (SMD -0.76, 95% CI -1.41 to -0.12) and insulin concentrations (SMD -0.77, 95% CI -1.50 to -0.04). Findings regarding body weight, total energy intake, lipids, inflammatory markers, and gut hormones remained contradictory.
Kellow NJ, Coughlan MT, Reid CM Br J Nutr, 2014. PMID 24230488
2014 / Meta-analysis of randomized controlled trials
A meta-analysis of 6 randomized placebo-controlled trials evaluated ginger for early pregnancy nausea and vomiting among 508 participants (256 receiving ginger and 252 receiving placebo). Consuming about 1 g of ginger daily for at least 4 days increased the likelihood of symptom improvement fivefold. The authors noted heterogeneity across the trials and emphasized that clinical value and safety profiles require further clarification.
Thomson M, Corbin R, Leung L J Am Board Fam Med, 2014. PMID 24390893
2014 / Meta-analysis of case-control and cohort studies
A meta-analysis of 37 case-control and seven cohort studies, including 424,867 participants and 18,852 GI neoplasm cases, assessed egg intake. Highest versus lowest egg consumption was associated with a slight increase in GI neoplasm risk (OR 1.15; 95% CI: 1.09-1.22), with a stronger link for colon cancer (OR 1.29; 95% CI: 1.14-1.46). Dose-response analyses also showed modest risk increases across categories of weekly egg consumption.
Shows an association, not proof of cause and effect.
Tse G, Eslick GD Eur J Nutr, 2014. PMID 24500371
2014 / Systematic review and meta-analysis of randomized controlled trials
A systematic review evaluated 14 randomized controlled trials with 906 adults experiencing irritable bowel syndrome. Fiber supplementation significantly decreased the risk of persistent symptoms compared to control therapies (RR=0.86; 95% CI 0.80-0.94; NNT=10; 95% CI 6-33). Benefit occurred specifically with soluble fiber (RR=0.83; 95% CI 0.73-0.94; NNT=7), whereas bran showed no significant effect (RR=0.90; 95% CI 0.79-1.03).
Moayyedi P, Quigley EM, Lacy BE, et al. Am J Gastroenterol, 2014. PMID 25070054
2013 / Systematic review of randomized controlled trials
A systematic review examined four randomized controlled trials assessing oral ginger for nausea and vomiting in pregnancy. In all four trials, ginger significantly outperformed placebo in reducing vomiting frequency and nausea intensity. Adverse events were typically mild and infrequent, though optimal dosing and potential drug interactions remain unestablished.
Ding M, Leach M, Bradley H Women Birth, 2013. PMID 22951628
2013 / Cross-sectional study and meta-analysis
A cross-sectional study in Japan evaluated 8,013 healthy adults (5,451 coffee drinkers and 2,562 non-drinkers) alongside an integrated meta-analysis. Multiple logistic regression revealed no significant link between coffee intake and gastric ulcer, duodenal ulcer, reflux esophagitis, or non-erosive reflux disease. The accompanying meta-analysis also detected no significant association of coffee intake with gastric or duodenal ulcers.
Shows an association, not proof of cause and effect.
Shimamoto T, Yamamichi N, Kodashima S, et al. PLoS One, 2013. PMID 23776588
2013 / Systematic review and meta-analysis of case-control studies
A systematic review of ten case-control studies evaluated dietary fiber intake and esophageal cancer risk. Comparing extreme categories of consumption, pooled analysis of eight studies showed that high fiber intake was inversely associated with esophageal adenocarcinoma (OR 0.66, 95% CI 0.44 to 0.98). A similar but non-significant inverse association was observed across five studies of squamous cell carcinoma (OR 0.61, 95% CI 0.31 to 1.20).
Shows an association, not proof of cause and effect.
Coleman HG, Murray LJ, Hicks B, et al. Nutr Rev, 2013. PMID 23815145